Login / Signup

Microbiological Quality of Selected Local and Imported Non-Sterile Pharmaceutical Products in Dar es Salaam, Tanzania.

David T MyembaGeorge M BwireRaphael Zozimus Sangeda
Published in: Infection and drug resistance (2022)
We recommend that pharmaceutical manufacturers abide by good manufacturing, distribution and storage practices to limit contamination and cross-contamination of products. Responsible drug regulatory authorities should heighten the frequency of inspection of manufacturing facilities and regularly conduct post-marketing surveillance (PMS) of registered products to assess continued conformity to GMP guidelines. Future studies should involve samples collected directly from manufacturing sites.
Keyphrases
  • risk assessment
  • drinking water
  • healthcare
  • primary care
  • health risk
  • transcription factor
  • emergency department
  • clinical practice
  • quality improvement
  • biofilm formation
  • staphylococcus aureus
  • heavy metals
  • adverse drug